Vysis: Broader acceptance of FISH test as HER-2 DNA probe

Article Abstract:

Vysis has reported that in excess of 20 of the nations's leading cancer centers and commercial laboratories have contracted to provide the PathVysion HER-2 DNA Prjobe Kit for detecting and quantifying the HER-2 gene in breast cancer patients.

Contracts & orders received, Biological Product (except Diagnostic) Manufacturing, Drugs, DNA Probes

---

Cancer: Cytoclonal: lung cancer monoclonal antibody patent claim

Article Abstract:

Dallas, TX-based Cytoclonal Pharmaceutics has received patent claim allowance by the US Patent Office for its monoclonal antibody LCG-MAb which recognizes a protein on the surface of non-small cell lung cancer.

In-Vitro Diagnostic Substance Manufacturing, Diagnostic substances, Monoclonal Antibodies for Diagnosis, Monoclonal antibodies, Diagnosis, Cytoclonal Pharmaceutics Inc., CYPH

---

Genotyping?phenotyping: Enzo Biochem: genomic analysis/DNA diagnostics patents

Article Abstract:

Farmington, NY-based Enzo Biochem received two US patents encompassing strategic areas applicable to genomic analysis and DNA diagnostics.

DNA-Based Tests, DNA identification, Enzo Biochem Inc., ENZ

Similar abstracts:

• Abstracts: The implementation of business process reengineering in American and Canadian hospitals. Quality improvement: beyond the institution
• Abstracts: Study results: prediction and prevention of pressure ulcers in surgical patients. Pressure ulcer risk factors in the operating room
• Abstracts: A note on entry by small hospitals. Exploring social welfare functions and violation of monotonicity: an example from inequalities in health-a comment
• Abstracts: Auto-immune and allergy tests: new sources for diagnostic growth? Drug discovery: Bioinformatics: collaloration to develop bio-info software tools
• Abstracts: Medicine and applications. Becton dDckinson: research alliance in genomics based oncology

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.